OrbiMed Israel Partners Limited Partnership plan to sell securities of Adicet Bio, Inc. under Form 144

OrbiMed Israel Partners Limited Partnership filed Form 144 to notify SEC of plan to sell 64242 units of Adicet Bio, Inc. securities around 2026-04-07, with aggregate market value of $413,076.06. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.67% of total outstanding units;